Cardiac Arrest Management After Robotic Mitral Valve Replacement
Initial Response and Rhythm Identification
- The American Heart Association recommends immediately attaching defibrillator/pacing pads without delay to identify the cardiac rhythm, while simultaneously administering 100% oxygen and ensuring adequate ventilation in patients who arrest after robotic mitral valve replacement 1.
- The priority is rapid identification of reversible causes specific to post-cardiac surgery patients before initiating external compressions, with a focus on checking for pulse and responsiveness within 10 seconds 1, 2, 3.
Critical Deviation: Address Reversible Causes FIRST
- The American College of Cardiology recommends rapidly assessing and treating surgical complications, such as tamponade, hypovolemia, or ventricular dysfunction, before starting external chest compressions in post-cardiac surgery patients 1.
- Bedside echocardiography is recommended to identify tamponade, hypovolemia, or ventricular dysfunction in patients who arrest after robotic mitral valve replacement 1.
- Rapid fluid bolus and blood products are recommended if hypovolemia or bleeding is suspected in post-cardiac surgery patients 1.
- Reverse anticoagulation is recommended if active bleeding is present in patients who arrest after robotic mitral valve replacement 1.
- Needle decompression is recommended if tension pneumothorax is suspected, particularly after robotic surgery via thoracotomy approach 1.
- Checking and correcting electrolytes, such as potassium, magnesium, and calcium, is recommended immediately in post-cardiac surgery patients 1, 4.
Rhythm-Specific Management
- The American Heart Association recommends defibrillating immediately with up to 3 stacked shocks before considering external compressions in patients with VF/pulseless VT after robotic mitral valve replacement 1.
- Biphasic 120-200J or monophasic 360J defibrillation is recommended per manufacturer recommendations for patients who arrest after robotic mitral valve replacement 5, 6.
- Amiodarone 300 mg IV bolus or lidocaine 1-1.5 mg/kg is recommended for shock-refractory VF/pVT in post-cardiac surgery patients 1, 5.
Medication Modifications
- The American College of Cardiology recommends using epinephrine cautiously at standard dose, but considering lower doses or delayed administration compared to standard ACLS in post-cardiac surgery patients 1.
- The 2018 AHA update removed the preference for amiodarone over lidocaine for shock-refractory VF/pVT, as neither has shown long-term survival benefit 5, 7.
Advanced Interventions
- Extracorporeal CPR (ECPR) is recommended for select refractory cardiac arrest patients when provided within an appropriately trained system, particularly in post-cardiac surgery patients where conventional CPR is failing and resternotomy is not immediately feasible 8.
Post-ROSC Management
- Maintaining MAP ≥65 mmHg with vasopressors, but avoiding excessive hypertension that could disrupt surgical repairs, is recommended in post-cardiac surgery patients after ROSC 1.
- Targeting SpO2 92-98% to avoid both hypoxia and hyperoxemia is recommended in patients who arrest after robotic mitral valve replacement 1, 2.
- Performing immediate 12-lead ECG and considering coronary angiography if ischemia is suspected is recommended in post-cardiac surgery patients after ROSC 1, 8.
- Initiating targeted temperature management is recommended if the patient doesn't follow commands after ROSC 1.
- Continuous monitoring for re-arrest is recommended, as post-cardiac surgery patients remain at high risk 1.